Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioImpacts is Scopus-indexed (Q1, CiteScore 4.2), WoS SCIE, DOAJ. Published by Tabriz University of Medical Sciences.
Checked against the index lists dated .
ISSN 2228-5652Verify ISSN ↗2228-5660Verify ISSN ↗
Publisher: Tabriz University of Medical Sciences
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 123 / 669 | 81st | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 91 / 223 | 59th | Q2 |
| Pharmaceutical Science | 81 / 191 | 57th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 4.2.
BioImpacts is Q1 in Medicine (all) (rank 123 of 669), Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 91 of 223) and Q2 in Pharmaceutical Science (rank 81 of 191), by CiteScore 2025.
BioImpacts is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.568, quartile Q2, with an H-index of 50.
BioImpacts is published by Tabriz University of Medical Sciences. Its print ISSN is 2228-5652 and its online ISSN is 2228-5660.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
BioImpacts has an h-index of 46 and a 2-year mean of 2.91 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q1. On 2-year citations it ranks #93 of 646 Scopus journals in Medicine (all).
BioImpacts published 66 papers in 2025; its busiest recent year was 2024 with 80. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from Iran (46.6%), China (14.1%) and India (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (5.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.